Rooted in the science of endomicrobial ecology, Native Microbials enters the U.S. market
“Our new brand positioning as Native Microbials embodies and clearly communicates our unique approach to provide products that achieve optimal animal outcomes using naturally occurring microbes native to each animal species,” said Michael Seely, chief executive officer of Native Microbials. “As Native Microbials, our mission is to improve the health and well-being of all animals around the world. We deliver breakthrough microbial solutions through our unwavering commitment to deep science.”
The company’s new brand identity comes shortly after securing $46 million in Series B funding earlier this year. As a result, Native Microbials is building momentum to expand their products and services beyond their current markets.
The Native Microbials team is well-positioned ahead of the launch of the world’s first endomicrobial products, Galaxis and Avius Protect, in the U.S.. These products are underpinned by the world’s largest microbial genomics datasets at Native, which enable both a more coherent deciphering of the microbial communities in and on animals, but also the ability to develop products that are highly effective, safe and operate in harmony with animal welfare and production.
“Our products set a high bar for us and others to chase in the pursuit of helping customers,” said Seely. “We look forward to delivering our microbes and microbial insights in order to help our customers and their advisors continue to care for their animals in ways that are not only harmonious with their animals biology and end consumer needs, but at the same time create value.”